7ld0
From Proteopedia
(Difference between revisions)
(One intermediate revision not shown.) | |||
Line 3: | Line 3: | ||
<StructureSection load='7ld0' size='340' side='right'caption='[[7ld0]], [[Resolution|resolution]] 3.10Å' scene=''> | <StructureSection load='7ld0' size='340' side='right'caption='[[7ld0]], [[Resolution|resolution]] 3.10Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'> | + | <table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=7LD0 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=7LD0 FirstGlance]. <br> |
- | </td></tr><tr id=' | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">Electron Microscopy, [[Resolution|Resolution]] 3.1Å</td></tr> |
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7ld0 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7ld0 OCA], [https://pdbe.org/7ld0 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7ld0 RCSB], [https://www.ebi.ac.uk/pdbsum/7ld0 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7ld0 ProSAT]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7ld0 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7ld0 OCA], [https://pdbe.org/7ld0 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7ld0 RCSB], [https://www.ebi.ac.uk/pdbsum/7ld0 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7ld0 ProSAT]</span></td></tr> | ||
</table> | </table> | ||
- | == Function == | ||
- | [[https://www.uniprot.org/uniprot/SARM1_HUMAN SARM1_HUMAN]] Negative regulator of MYD88- and TRIF-dependent toll-like receptor signaling pathway which plays a pivotal role in activating axonal degeneration following injury. Promotes Wallerian degeneration an injury-induced axonal death pathway which involves degeneration of an axon distal to the injury site. Can activate neuronal death in response to stress. Regulates dendritic arborization through the MAPK4-JNK pathway. Involved in innate immune response. Inhibits both TICAM1/TRIF- and MYD88-dependent activation of JUN/AP-1, TRIF-dependent activation of NF-kappa-B and IRF3, and the phosphorylation of MAPK14/p38.<ref>PMID:15123841</ref> <ref>PMID:16964262</ref> <ref>PMID:16985498</ref> <ref>PMID:20306472</ref> | ||
- | <div style="background-color:#fffaf0;"> | ||
- | == Publication Abstract from PubMed == | ||
- | Axon degeneration is a central pathological feature of many neurodegenerative diseases. Sterile alpha and Toll/interleukin-1 receptor motif-containing 1 (SARM1) is a nicotinamide adenine dinucleotide (NAD(+))-cleaving enzyme whose activation triggers axon destruction. Loss of the biosynthetic enzyme NMNAT2, which converts nicotinamide mononucleotide (NMN) to NAD(+), activates SARM1 via an unknown mechanism. Using structural, biochemical, biophysical, and cellular assays, we demonstrate that SARM1 is activated by an increase in the ratio of NMN to NAD(+) and show that both metabolites compete for binding to the auto-inhibitory N-terminal armadillo repeat (ARM) domain of SARM1. We report structures of the SARM1 ARM domain bound to NMN and of the homo-octameric SARM1 complex in the absence of ligands. We show that NMN influences the structure of SARM1 and demonstrate via mutagenesis that NMN binding is required for injury-induced SARM1 activation and axon destruction. Hence, SARM1 is a metabolic sensor responding to an increased NMN/NAD(+) ratio by cleaving residual NAD(+), thereby inducing feedforward metabolic catastrophe and axonal demise. | ||
- | + | ==See Also== | |
- | + | *[[SARM1 3D structures|SARM1 3D structures]] | |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
- | [[Category: Human]] | ||
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
- | [[Category: Gu | + | [[Category: Gu W]] |
- | [[Category: Jia | + | [[Category: Jia X]] |
- | [[Category: Kobe | + | [[Category: Kobe B]] |
- | [[Category: Landsberg | + | [[Category: Landsberg MJ]] |
- | [[Category: Luo | + | [[Category: Luo Z]] |
- | [[Category: Nanson | + | [[Category: Nanson JD]] |
- | [[Category: Ve | + | [[Category: Ve T]] |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + |
Current revision
Cryo-EM structure of ligand-free Human SARM1
|
Categories: Large Structures | Gu W | Jia X | Kobe B | Landsberg MJ | Luo Z | Nanson JD | Ve T